{"disease":{"id":"infections-pseudomonas","name":"infections pseudomonas"},"drugs":{"marketed":[{"drug_id":"colistimethate","indication_name":"Infections Due to Pseudomonas aeruginosa","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"COLISTIMETHATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":30,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03638830","title":"Safety and Efficacy Study of Ftortiazinon in the Treatment of Patients With Complicated Urinary Tract Infections Caused by P. Aeruginosa","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":777,"lead_sponsor_name":"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation","has_results":false},{"nct_id":"NCT07056881","title":"Monotherapy vs Combination Therapy for Bone Infections Caused by Pseudomonas Aeruginosa","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Centre Hospitalier de Saint-Denis","has_results":false},{"nct_id":"NCT03510351","title":"Clinical Outcomes With Ceftolozane-tazobactam for MDR Pseudomonas Infections","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Temple University","has_results":false},{"nct_id":"NCT06548841","title":"Development and Validation of (Bio)Sensors for the Identification of Pathogens","phase":"","overall_status":"COMPLETED","enrollment_count":149,"lead_sponsor_name":"University of Bologna","has_results":false},{"nct_id":"NCT03262142","title":"Targeted AntiBiotics for Chronic Pulmonary Diseases","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":51,"lead_sponsor_name":"Chronic Obstructive Pulmonary Disease Trial Network, Denmark","has_results":false},{"nct_id":"NCT01069705","title":"Second Open Label Extension to Bridging Study CTBM100C2303","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT01449838","title":"Phase I Study of Colistin Methanesulfonate Sodium","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"GlaxoSmithKline","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}